Santiago García‐López

Author

Hospital Universitario Miguel Servet ORCID

Also Known As

Ana Echarri Piudo, Daniel Bergemalm, J Pineda, Lucía Márquez, M F García-Sepulcre, S Garcia-Lopez, S Garcia-López, S García, S García López, S García-Lopez

209

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Miguel Servet Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Universitario de La Princesa Hospital Universitario Reina Sofía Hospital Clínico Universitario Lozano Blesa

About

Santiago García‐López is an author at Hospital Universitario Miguel Servet specializing in medicine, gastroenterology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	514
2	Public Health	2	2	100
3	Language Studies	1	1	16
4	Comparative Literature	1	1	16
5	Emergency Medicine	1	1	259

Santiago García‐López

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice Ángel Lanas, Luis A. García‐Rodríguez, Mónica Polo-Tomás, The American Journal of Gastroenterology	2009	578
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants Ángel Lanas, Patricia Carrera‐Lasfuentes, Yolanda Arguedas, Clinical Gastroenterology and Hepatology Gastrointestinal BleedingThrombosisNonsteroidal Anti-inflammatory DrugsAntiplatelet AgentsCardiovascular Disease	2014	259
Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease María José Casanova, María Chaparro, Eugeni Domènech, The American Journal of Gastroenterology	2013	232
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study María José Casanova, María Chaparro, Valle García–Sánchez, The American Journal of Gastroenterology	2016	112
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study Carlos Chavarría, María José Casanova, María Chaparro, Journal of Crohn s and Colitis	2019	96
Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry María Chaparro, Ana Garre, Elena Ricart, Alimentary Pharmacology & Therapeutics	2018	95
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryImmunologyGastroenterologyMaintenance Therapy	2021	89
Optimal management of iron deficiency anemia due to poor dietary intake Santiago García López, Aspuru Rubio, Villa Poza, International Journal of General Medicine NutritionIron MetabolismNutrition DevelopmentPublic Health NutritionIron Deficiency Anemia	2011	87
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2019	70
Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2020	65

Page 1